selected publications
-
academic article
- The Research Centers in Minority Institutions (RCMI) Translational Research Network: Building and Sustaining Capacity for Multi-Site Basic Biomedical, Clinical and Behavioral Research.. Ethnicity & disease. 29:135-144. 2019
- Estrogen receptor-beta is a potential target for triple negative breast cancer treatment.. Oncotarget. 9:33912-33930. 2018
- Combination treatment with flavonoid morin and telomerase inhibitor MST‑312 reduces cancer stem cell traits by targeting STAT3 and telomerase.. International journal of oncology. 49:487-98. 2016
- Expression of Wnt3 activates Wnt/β-catenin pathway and promotes EMT-like phenotype in trastuzumab-resistant HER2-overexpressing breast cancer cells.. Molecular cancer research : MCR. 10:1597-606. 2012